Keyphrases
Kidney Transplantation
100%
AIDS/HIV
100%
Confidence Interval
100%
Hazard Ratio
60%
Kidney Transplant Recipients
40%
CD4+ T
40%
Cell Count
40%
Human Immunodeficiency Virus Infection
40%
Rejection Rate
40%
Immunosuppression
20%
Survivors
20%
Infectious Diseases
20%
Allergy Disease
20%
Antiretroviral Therapy
20%
Human Immunodeficiency Virus Type 1 (HIV-1)
20%
National Database
20%
Pretransplant
20%
Associated Complications
20%
MRNA Level
20%
Graft Loss
20%
Non-randomized Trial
20%
Infected Patients
20%
Induction Therapy
20%
Immunosuppression Management
20%
Antithymocyte Globulin
20%
Proportional Hazards Model
20%
Opportunistic Infections
20%
Grafting Ratio
20%
Patient Survival Rate
20%
Antiretroviral Regimens
20%
Living Donor Transplant
20%
High Rejection
20%
Hazard Analysis
20%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Kidney Transplantation
100%
Hazard Ratio
60%
Kidney Graft
40%
Immunosuppressive Treatment
40%
Survival Rate
40%
Human Immunodeficiency Virus Infection
40%
T-Helper Cell
40%
Cell Count
40%
Thymocyte Antibody
20%
Antiretroviral Therapy
20%
Proportional Hazards Model
20%
Human Immunodeficiency Virus 1
20%
Opportunistic Infection
20%
Graft Failure
20%
Graft Survival
20%
Biopsy Technique
20%
Infectious Disease
20%
Immunotherapy
20%
Living Donors
20%
Nursing and Health Professions
Human Immunodeficiency Virus
100%
Kidney Transplantation
100%
Confidence Interval
83%
Hazard Ratio
50%
CD4 Lymphocyte Count
33%
Survival Rate
33%
Human Immunodeficiency Virus Infection
33%
Kidney Graft
33%
Immunosuppressive Treatment
33%
National Health Organization
16%
Immunotherapy
16%
Graft Failure
16%
Antiretroviral Therapy
16%
Proportional Hazards Model
16%
Virus Typing
16%
Graft Survival
16%
Biopsy Technique
16%
Opportunistic Infection
16%
Thymocyte Antibody
16%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Kidney Transplantation
100%
Immunosuppression
40%
Human Immunodeficiency Virus Infection
40%
Survival Rate
40%
CD4 Lymphocyte Count
40%
Human Immunodeficiency Virus 1
20%
Blood Plasma
20%
Anti-Thymocyte Globulin
20%
Immunotherapy
20%
Opportunistic Infection
20%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Survival Rate
40%
Human Immunodeficiency Virus Infection
40%
Graft Failure
20%
Opportunistic Infection
20%
Thymocyte Antibody
20%
Human Immunodeficiency Virus 1
20%
Immunotherapy
20%
Diseases
20%